NextCure, launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Market
Immuno-oncology
Location
New Haven,
CT,
USA
Coinvestors
Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, Pfizer Strategic Investments Group, Sofinnova Ventures, ArrowMark Partners, Bay City Capital, Hillhouse Capital Management, NS Investment, Pfizer Venture Investments, Ping An Ventures, Quan Capital, Surveyor Capital, Taiho Ventures